Back to top

Analyst Blog

ResMed Inc. (RMD - Analyst Report) reported earnings per share (‘EPS’) of 49 cents in the first quarter of fiscal 2013, comfortably beating the Zacks Consensus Estimate of 46 cents. The results were also better than the year-ago EPS by 48%. Apart from increased sales and higher margin, a 5.2% fall in shares outstanding contributed to the EPS improvement.

Revenues increased 8% year over year (up 12% at constant exchange rates or CER) to $339.7 million, almost in line with the Zacks Consensus Estimate. Based on a favorable product mix and vastly under-penetrated and growing sleep-disorder breathing market, revenues in the Americas increased 15% to $194.4 million but remained flat (up 9% at CER) outside the Americas at $145.4 million. Strong year-over-year growth in flow generator and mask categories contributed to the overall growth.  

The company reported domestic flow generator sales of $84.8 million in the quarter, up 17% year over year due to strong growth in Automatic Positive Airway Pressure (“APAP”) systems. Masks and other sales were $109.6 million, up 13% year over year, driven by strong contributions across the mask product range and continued growth in accessories. Outside the Americas, Flow Generator sales were $96.7 million, down 2% year over year but up 7% at CER. Outside Americas Masks and other sales were $48.6 million, up 4% (up 13% at CER) year over year. At CER, worldwide Flow Generator sales increased 11% year over year, while masks and other increased 13%.

Gross profit climbed up 12.7% to $208.6 million leading to a 260 basis points (bps) expansion in gross margin to 61.4%. Selling, general and administrative, and research and development expenses during the quarter were up 4% (up 9% at CER) to $98.3 million and up 4% (up 6%) to $27.2 million, respectively, favorably impacted by an appreciating US dollar. Nevertheless, operating margin increased 390 bps to 24.5% during the quarter.

ResMed exited the quarter with cash and cash equivalents of $890.6 million compared with $809.5 million at the end of fiscal 2012. Cash flow generated from operations was $78.3 million during the first quarter.

ResMed repurchased 216,000 shares for $8.1 million during the quarter (13.6 million shares for $391.2 million in fiscal 2012) and was left with the authorization to repurchase 8.6 million shares. In fiscal 2013, ResMed intends to purchase at least 2 million shares through its existing share buyback program. Additionally, the Board of Directors declared a quarterly dividend of 17 cents per share, payable on December 18, 2012.

Despite the challenging macroeconomic scenario in Europe, we are encouraged by ResMed’s overall improved top and bottom-line performances during the first quarter of fiscal 2013. Presently, ResMed is emphasizing building strategic relationships in order to penetrate further in the domestic and international arena that includes the 5-year exclusive distribution agreement with CareFusion (CFN - Analyst Report).

Currently, ResMed retains a short-term Zacks #3 (Hold Rank).

Please login to or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research


Are you a new Zacks Member or a visitor to

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
RPC INC RES 24.91 +8.35%
LITHIA MOTO… LAD 94.59 +4.60%
DELTA AIR L… DAL 39.15 +3.90%
FLAMEL TECH… FLML 14.51 +3.50%
SOUTHWEST A… LUV 28.87 +2.92%